Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 2329-0358

Get your full text copy in PDF

Processings, storage and experimental transplantation of human fetal pancreatic cells

Alberto Hayek, Gillian M Beattie

Ann Transplant 1997; 2(3): 46-54

ID: 497172

Almost 25 years ago following reports of successful shortterm culture of the human fetal pancreas, it was suggested that fetal pancreatic cells could be used as a cell-based insulin delivery system in insulin-dependent diabetes (IDDM) [1]. Several trials using fetal pancreatic explants in transplantation procedures to patients with IDDM were undertaken mostly in Eastern European countries and China (reviewed in [2]). However, the results of those trials could not be analyzed because the information reported was insufficient to draw valid conclusions. Limited clinical trials in Australia [3] and the U.S. [2] indicated that the tissue was antigenic and that it could survive after transplantation under the kidney capsule in immunosuppressed patients who had received a kidney transplant.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree